TROYA Therapeutics
PrivateLast Round
Accelerator
Jan 15, 2026
Total Funding Raised
$2.77M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
TROYA Therapeutics is a biotechnology company that develops engineered protein-based therapeutics designed to improve drug control for safety and efficacy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TROYA Therapeutics Comparables
Compare TROYA Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bonum Therapeutics | 84% | |
| Revitope Oncology, Inc. | 80% | |
| CytomX Therapeutics | 78% |
TROYA Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jan 15, 2026 | ||||
| Accelerator | Aug 29, 2024 | ||||
| Grant | Dec 14, 2023 |
TROYA Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Novo Nordisk Foundation | Grant |
| BioInnovation Institute | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 15, 2026
$1.64M round led by BioInnovation Institute
- Aug 29, 2024
$550K round led by BioInnovation Institute
TROYA Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about TROYA Therapeutics's valuation, stock price, and market status.
Is TROYA Therapeutics a public or private company?
TROYA Therapeutics is a private company.
What is the current stock price of TROYA Therapeutics?
TROYA Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is TROYA Therapeutics worth (valuation)?
Valuation information for TROYA Therapeutics is not publicly available.
Can I buy TROYA Therapeutics stock?
TROYA Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was TROYA Therapeutics's last funding round?
TROYA Therapeutics's most recent funding round was Accelerator on January 15, 2026.
Who are the main investors in TROYA Therapeutics?
Investor information for TROYA Therapeutics is not publicly disclosed.
Will TROYA Therapeutics IPO soon?
No public IPO plans have been announced for TROYA Therapeutics.
How can I track TROYA Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TROYA Therapeutics's secondary market activity and sign up for updates.